EnGeneIC's Series B - II Round

EnGeneIC raised a round of funding on July 29, 2015.

EnGeneIC is an emerging biopharmaceutical company focused on developing its proprietary EDV nanocell platform for the targeted delivery of cancer therapeutic and other therapeutic molecules. The comp…

Articles about EnGeneIC's Series B - II Round: